Board of Directors


Halden Conner

  • Chairman, CEO, Co-Founder, Nacuity Pharmaceuticals, Inc.
  • Director, Private Access, Inc.
  • Co-founder, Protom International
  • Former Alcon Laboratories Board Member

David Wohlberg, esq.

  • Vice-Chairman, Co-Founder, Nacuity Pharmaceuticals, Inc.
  • Former President, ImmunoCellular Therapeutics, Inc.
  • Managing Principal, Birtcher Anderson

Gerald D. Cagle, Ph.D.

  • 31 years at Alcon Laboratories, including serving as Global Head R&D, Chief Scientific Officer and VP Regulatory Affairs
  • Holds more than 20 issued patents and has authored numerous peer reviewed scientific articles
  • Director, Aerie, Clearside Biomedical, GrayBug Drug Delivery and FFB-CRI

Robin Steele, J.D., LL.M.

  • Director, Daré Bioscience, Inc. and Alveo Technologies, Inc.
  • Former Senior Vice President, General Counsel, and Secretary of InterMune, Inc.
  • Former Vice President of Legal Affairs for North America, Elan Pharmaceuticals
  • Director, Alios Biopharma and Targanta Therapeutics

Benjamin R. Yerxa, Ph.D.

  • CEO, Foundation Fighting Blindness and RD Fund
  • Former President and Chief Scientific Officer, Envisia Therapeutics
  • Former Chief Scientific Officer, Liquidia Technologies
  • Former Vice President for Research and Development, Clearside Biomedical